These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines. Wang M; Fudge K; Rhim JS; Stearns ME Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794 [TBL] [Abstract][Full Text] [Related]
3. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299 [TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695 [TBL] [Abstract][Full Text] [Related]
6. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572 [TBL] [Abstract][Full Text] [Related]
8. Overview of matrix metalloproteinase expression in cultured human cells. Giambernardi TA; Grant GM; Taylor GP; Hay RJ; Maher VM; McCormick JJ; Klebe RJ Matrix Biol; 1998 Mar; 16(8):483-96. PubMed ID: 9550265 [TBL] [Abstract][Full Text] [Related]
9. Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes. Airola K; Fusenig NE J Invest Dermatol; 2001 Jan; 116(1):85-92. PubMed ID: 11168802 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C; Loher F; Zang C; Ismair MG; Petrides PE Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746 [TBL] [Abstract][Full Text] [Related]
11. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Hamasuna R; Kataoka H; Moriyama T; Itoh H; Seiki M; Koono M Int J Cancer; 1999 Jul; 82(2):274-81. PubMed ID: 10389763 [TBL] [Abstract][Full Text] [Related]
12. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Kusano K; Miyaura C; Inada M; Tamura T; Ito A; Nagase H; Kamoi K; Suda T Endocrinology; 1998 Mar; 139(3):1338-45. PubMed ID: 9492070 [TBL] [Abstract][Full Text] [Related]
13. The effect of E1A transfection on MMP-9 expression and metastatic potential. Bernhard EJ; Hagner B; Wong C; Lubenski I; Muschel RJ Int J Cancer; 1995 Mar; 60(5):718-24. PubMed ID: 7860147 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes. Kobayashi T; Hattori S; Nagai Y; Tajima S; Nishikawa T Dermatology; 1998; 197(1):1-5. PubMed ID: 9693177 [TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis. Tsukifuji R; Tagawa K; Hatamochi A; Shinkai H Br J Cancer; 1999 Jun; 80(7):1087-91. PubMed ID: 10362121 [TBL] [Abstract][Full Text] [Related]
17. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro. Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463 [TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Tanaka K; Iwamoto Y; Ito Y; Ishibashi T; Nakabeppu Y; Sekiguchi M; Sugioka Y Cancer Res; 1995 Jul; 55(13):2927-35. PubMed ID: 7796421 [TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium. Tao Y; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. Rawdanowicz TJ; Hampton AL; Nagase H; Woolley DE; Salamonsen LA J Clin Endocrinol Metab; 1994 Aug; 79(2):530-6. PubMed ID: 8045973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]